Lena Tschiderer, Sanne A E Peters, Yvonne T van der Schouw, Stephen Burgess, Janneke Luijken, Cheyenne Bijmolt, Houda Soliman, Adam S Butterworth, Angela M Wood, Tammy Y N Tong, Christina C Dahm, Lisa Seekircher, Anne Tjønneland, Lene Mellemkjær, Matthias B Schulze, Giovanna Masala, Sabina Sieri, Salvatore Panico, Carlotta Sacerdote, Jolanda M A Boer, W M Monique Verschuren, Carlota Castro-Espin, Dafina Petrova, Sandra M Colorado-Yohar, Conchi Moreno-Iribas, Elisabete Weiderpass, Alicia K Heath, Ioanna Tzoulaki, Peter Willeit, N Charlotte Onland-Moret
{"title":"Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses.","authors":"Lena Tschiderer, Sanne A E Peters, Yvonne T van der Schouw, Stephen Burgess, Janneke Luijken, Cheyenne Bijmolt, Houda Soliman, Adam S Butterworth, Angela M Wood, Tammy Y N Tong, Christina C Dahm, Lisa Seekircher, Anne Tjønneland, Lene Mellemkjær, Matthias B Schulze, Giovanna Masala, Sabina Sieri, Salvatore Panico, Carlotta Sacerdote, Jolanda M A Boer, W M Monique Verschuren, Carlota Castro-Espin, Dafina Petrova, Sandra M Colorado-Yohar, Conchi Moreno-Iribas, Elisabete Weiderpass, Alicia K Heath, Ioanna Tzoulaki, Peter Willeit, N Charlotte Onland-Moret","doi":"10.1093/eurjpc/zwaf051","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Observational studies have shown a U-shaped association between age at menarche (AAM) and cardiovascular disease (CVD). We assessed non-linearity of the observational association and the potential causal relationship between AAM and CVD using data from the European Prospective Investigation into Cancer and Nutrition-Cardiovascular Disease (EPIC-CVD) study and the UK Biobank.</p><p><strong>Methods and results: </strong>We included women without pre-existing myocardial infarction (MI) or stroke at baseline. We estimated hazard ratios for incident MI, ischaemic and haemorrhagic stroke later in life using Cox regression in observational analyses and conducted non-linear Mendelian randomization (MR) based on fractional polynomials and linear MR based on inverse-variance weighted regression. We analysed 283 210 women with a median AAM of 13 (IQR 12-14) years in both EPIC-CVD and the UK Biobank, of which 8468 experienced a MI, 5501 an ischaemic and 1887 a haemorrhagic stroke. The association between AAM and MI and ischaemic stroke was U-shaped with higher risks in women aged ≤12 and ≥16 compared with those aged 13 years at menarche. Our MR analyses found no evidence for non-linearity between genetically proxied AAM and any CVD endpoint later in life, but each year higher genetically proxied AAM was related to a lower risk of MI (hazard ratio 0.92 [95% CI 0.86-0.99]), but not to ischaemic and haemorrhagic stroke.</p><p><strong>Conclusion: </strong>This study supported non-linear observational associations between AAM and MI and ischaemic stroke. MR analyses suggested a causal relationship between higher AAM and risk of MI without an indication for non-linearity. There was no support for a potential causal link with ischaemic and haemorrhagic stroke.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":8.4000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf051","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: Observational studies have shown a U-shaped association between age at menarche (AAM) and cardiovascular disease (CVD). We assessed non-linearity of the observational association and the potential causal relationship between AAM and CVD using data from the European Prospective Investigation into Cancer and Nutrition-Cardiovascular Disease (EPIC-CVD) study and the UK Biobank.
Methods and results: We included women without pre-existing myocardial infarction (MI) or stroke at baseline. We estimated hazard ratios for incident MI, ischaemic and haemorrhagic stroke later in life using Cox regression in observational analyses and conducted non-linear Mendelian randomization (MR) based on fractional polynomials and linear MR based on inverse-variance weighted regression. We analysed 283 210 women with a median AAM of 13 (IQR 12-14) years in both EPIC-CVD and the UK Biobank, of which 8468 experienced a MI, 5501 an ischaemic and 1887 a haemorrhagic stroke. The association between AAM and MI and ischaemic stroke was U-shaped with higher risks in women aged ≤12 and ≥16 compared with those aged 13 years at menarche. Our MR analyses found no evidence for non-linearity between genetically proxied AAM and any CVD endpoint later in life, but each year higher genetically proxied AAM was related to a lower risk of MI (hazard ratio 0.92 [95% CI 0.86-0.99]), but not to ischaemic and haemorrhagic stroke.
Conclusion: This study supported non-linear observational associations between AAM and MI and ischaemic stroke. MR analyses suggested a causal relationship between higher AAM and risk of MI without an indication for non-linearity. There was no support for a potential causal link with ischaemic and haemorrhagic stroke.
期刊介绍:
European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.